Back

ZeleFelis

Ghost
zelefelis.com· irregular· Published yesterday

Research-style write-ups on biotech companies and their clinical programs, including Moderna's mRNA cancer vaccine and Viking Therapeutics' obesity drug. Each piece covers trial data, cash runway, regulatory dynamics and likely commercial outcomes from an investor's perspective.

modernamrna cancer vaccineintismeranviking therapeuticsvk2735glp-1obesity drugsbiotech stocksclinical trialsphase 3 datamerger and acquisitioninvestment research
Platform
Ghost
Frequency
Irregular
Latest issue
Oct 23, 2026
Language
English
Written for
Retail investors and students following biotech equities
Tone
analytical
Tracked since
Oct 24, 2026

Website: https://zelefelis.com/